Faye A. Luscombe

502 total citations
9 papers, 391 citations indexed

About

Faye A. Luscombe is a scholar working on Economics and Econometrics, Pediatrics, Perinatology and Child Health and Pharmacology. According to data from OpenAlex, Faye A. Luscombe has authored 9 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Economics and Econometrics, 2 papers in Pediatrics, Perinatology and Child Health and 1 paper in Pharmacology. Recurrent topics in Faye A. Luscombe's work include Health Systems, Economic Evaluations, Quality of Life (3 papers), Pharmaceutical Economics and Policy (2 papers) and Pharmaceutical studies and practices (2 papers). Faye A. Luscombe is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (3 papers), Pharmaceutical Economics and Policy (2 papers) and Pharmaceutical studies and practices (2 papers). Faye A. Luscombe collaborates with scholars based in United States. Faye A. Luscombe's co-authors include Helena C. Kraemer, P. J. Fox, Deborah J. Moritz, Raymond J. Townsend, Josephine Mauskopf, Joel Bobula, Jane T. Osterhaus, James P. Symons, Dale F. Kraemer and Mark Pierce and has published in prestigious journals such as The Journal of Infectious Diseases, Clinical Pharmacology & Therapeutics and Quality of Life Research.

In The Last Decade

Faye A. Luscombe

9 papers receiving 366 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Faye A. Luscombe United States 7 84 84 83 70 60 9 391
Francesco Paris Italy 13 151 1.8× 196 2.3× 35 0.4× 71 1.0× 22 0.4× 19 622
Dean G. Haxby United States 14 166 2.0× 139 1.7× 109 1.3× 90 1.3× 26 0.4× 29 769
Javier García del Pozo Spain 12 34 0.4× 65 0.8× 26 0.3× 75 1.1× 38 0.6× 33 455
Siegfried Schmidt United States 15 129 1.5× 97 1.2× 46 0.6× 128 1.8× 151 2.5× 43 910
Joanne Droney United Kingdom 17 149 1.8× 46 0.5× 58 0.7× 70 1.0× 11 0.2× 53 847
Margaret L. Ackman Canada 13 28 0.3× 45 0.5× 97 1.2× 56 0.8× 24 0.4× 41 613
Barry Cusack United States 7 97 1.2× 85 1.0× 82 1.0× 38 0.5× 12 0.2× 12 545
Cecilia Della Vedova Italy 9 65 0.8× 44 0.5× 134 1.6× 29 0.4× 12 0.2× 10 616
Pulin Yu China 14 355 4.2× 76 0.9× 206 2.5× 36 0.5× 20 0.3× 49 777
Brandon T. Suehs United States 14 46 0.5× 110 1.3× 80 1.0× 74 1.1× 64 1.1× 39 494

Countries citing papers authored by Faye A. Luscombe

Since Specialization
Citations

This map shows the geographic impact of Faye A. Luscombe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Faye A. Luscombe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Faye A. Luscombe more than expected).

Fields of papers citing papers by Faye A. Luscombe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Faye A. Luscombe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Faye A. Luscombe. The network helps show where Faye A. Luscombe may publish in the future.

Co-authorship network of co-authors of Faye A. Luscombe

This figure shows the co-authorship network connecting the top 25 collaborators of Faye A. Luscombe. A scholar is included among the top collaborators of Faye A. Luscombe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Faye A. Luscombe. Faye A. Luscombe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Luscombe, Faye A.. (2000). Health-related quality of life and associated psychosocial factors in irritable bowel syndrome: A review. Quality of Life Research. 9(2). 161–176. 54 indexed citations
2.
Luscombe, Faye A.. (2000). Health-Related Quality of Life Measurement in Type 2 Diabetes. Value in Health. 3. S15–S28. 84 indexed citations
3.
Gracon, Stephen, Margaret J. Knapp, Mark Pierce, et al.. (1998). Safety of Tacrine: Clinical Trials, Treatment IND, and Postmarketing Experience. Alzheimer Disease & Associated Disorders. 12(2). 93–101. 84 indexed citations
4.
Moritz, Deborah J., P. J. Fox, Faye A. Luscombe, & Helena C. Kraemer. (1997). Neurological and Psychiatric Predictors of Mortality in Patients With Alzheimer Disease in California. Archives of Neurology. 54(7). 878–885. 84 indexed citations
5.
Symons, James P., et al.. (1997). Tacrine hydrochloride treatment IND: methods for rapid physician and patient enrolment and data retrieval. Pharmacoepidemiology and Drug Safety. 6(6). 409–416. 1 indexed citations
6.
Townsend, Raymond J., et al.. (1995). Methodological and Conduct Principles for Pharmacoeconomic Research. PharmacoEconomics. 8(2). 169–174. 66 indexed citations
7.
Vestal, Robert E., et al.. (1991). Panel IV. Evaluation: The value and cost-effectiveness of drug utilization review programs*. Clinical Pharmacology & Therapeutics. 50(5 Pt 2). 636–638. 2 indexed citations
8.
Luscombe, Faye A.. (1985). Methodologic Issues in Pharmacy-Based Post-Marketing Surveillance. Drug Information Journal. 19(3). 269–274. 6 indexed citations
9.
Luscombe, Faye A., et al.. (1980). Mortality Due to Reye's Syndrome in Michigan: Distribution and Longitudinal Trends. The Journal of Infectious Diseases. 142(3). 363–371. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026